Case Report
Published on 17 Nov 2020
Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient
in Cancer Immunity and Immunotherapy

- 3,310 views
- 8 citations
Case Report
Published on 17 Nov 2020
in Cancer Immunity and Immunotherapy

Review
Published on 16 Nov 2020
in Antigen Presenting Cell Biology

Original Research
Published on 16 Nov 2020
in Vaccines and Molecular Therapeutics

Original Research
Published on 16 Nov 2020
in Microbial Immunology

Review
Published on 16 Nov 2020
in Molecular Innate Immunity

Original Research
Published on 16 Nov 2020
in Cancer Immunity and Immunotherapy

Original Research
Published on 16 Nov 2020
in Viral Immunology

Review
Published on 16 Nov 2020
in NK and Innate Lymphoid Cell Biology

Original Research
Published on 16 Nov 2020
in Comparative Immunology

Review
Published on 13 Nov 2020
in Molecular Innate Immunity

Original Research
Published on 13 Nov 2020
in T Cell Biology

Review
Published on 13 Nov 2020
in Autoimmune and Autoinflammatory Disorders

Review
Published on 13 Nov 2020
in Molecular Innate Immunity

Original Research
Published on 13 Nov 2020
in Microbial Immunology

Original Research
Published on 13 Nov 2020
in Viral Immunology

Original Research
Published on 13 Nov 2020
in Multiple Sclerosis and Neuroimmunology
